Towards the development of new biomaterials for use in angioplasty, star-shaped polylactic acids have been synthesised and shown to adhere well to living cells, by in vitro and in vivo experiments, and to hydrolyse over time in a physiologically relevant environment into biocompatible and bioabsorbable entities that are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Introduction
Cardiovascular disease, one of the leading causes for death worldwide, is often treated by stent implantation. However, the effectiveness of this treatment is impeded by in-stent restenosis (renarrowing of blood vessels), which affects ca. 20% of patients. [1] [2] [3] The metal skeletons of coronary stents provide mechanical stability, but have been associated with inflammation and thrombosis at the implanted site. To overcome this, the metal skeleton of stents is usually coated with biocompatible 4 and biodegradable 5 polymers which may incorporate drug molecules that inhibit thrombus and vascular smooth muscle cell (VSMC) proliferation.
Consequent to the application of the polymeric coating, the surface of the implanted stent is often lipophililic but over time it becomes increasingly hydrophilic due to the increasing presence of polar functionalities as the molecular weight of the biodegradable polymer is reduced and also due to the associated crystalline-to-amorphous transition caused by the plasticising effect of low molecular weight molecules from body fluids. [3] [4] [5] The degree of crystallinity of the polymeric matrix may be further affected by the plasticising effect of the incorporated drug molecules. [6] [7] [8] The combined effects of plasticisation and increasing hydrophilicity impact upon the therapeutically useful lifetime of the implant. Crystalline phase hydrolysis begins at the surface and propagates layer by layer whereas at the amorphous phase the initiation and propagation of chain scission is random. 5 Since the time dependence of the degradation rate is key to prolonging the release of the drug from the polymer matrix, the physical blending of drug molecules and polymer often results in lower degrees of crystallinity, and consequently accelerated rates of degradation. The drug eluting stents currently in use to overcome in-stent restenosis are often ineffective due to the rapid washout of the drugs from the local delivery sites in the arterial wall. 9 The use of sustained drug eluting stents carries alternative risks such as delayed endothelial regeneration and late thrombosis, which may cause implant rejection. Thus, the current impetus for the considerable research activities towards drug eluting stents is provided by the need to reduce the incidence of implantation-associated thrombosis. It has been reported that the vessel endothelium plays an important role in preventing thrombosis and hyper-plasia. 7, 9 Rapid smooth muscle cell proliferation and delay of re-endothelisation have been found to be the pathophysiological events leading to thrombosis and in-stent restenosis.
The involvement of lactide in biochemical processes renders the ring opening products of this monomer biocompatible and biodegradable materials for a range of biomedical applications, 4, 5 including those that require a potent pro-angiogenic effect. 10 Further, the chain length of polylactic acid (PLA), may be readily controlled since the material consists of hydrolysable polyester functional groups and reactive carboxyl/hydroxyl chain-terminating moieties. This in turn affords control over the hydrophilic-lipophilic balance (HLB) of the material. 11 HLB, a determinant parameter of the rate of biodegradation, may be tuned through the appropriate design of star-or comb-shaped molecular structures that allow the interplay between the polyester chain length and the number of terminal functional groups, 12 as illustrated in Fig. 1 .
In this work, the well-known drug dipyridamole has been used as a co-initiator with tin(II)ethylhexanoate (Sn(Oct)2) to effect control over the degradation/hydrolysis rate of the resultant polymer and to enhance its capability to inhibit thrombus formation and vasodilation. The molecular design is rationalised by literature observations that if constructed around a dipyridamole core, the resultant star-shaped PLA polymer may combine biocompatibility and controlled biodegradability with the therapeutic benefits (antithrombogesis, [13] [14] [15] anti-inflammation, 16, 17 and compatibility with the extra cellular matrix 18, 19 ) of the constitutional sub molecular units (Scheme 1). Thus, this paper also provides a preliminary assessment of star-shaped dipyridamole-cored PLA as a coating of coronary stents that may promote angiogenesis-facilitated re-endothelisation and prevent thrombosis and in-stent restenosis. Chloroform, hexane, ethanol, methanol and sulfuric acid were purchased from Rankem. All materials were used without further purification. Toluene (Rankem) was dried over a sodium wire. software) were performed on film structures that had been allowed to dry (room temperature, 24 h) in a dust-free environment. Synthesis L -Lactide or DL -lactide (2 g) was introduced into a round-bottomed flask (100 ml). Dry toluene (25 ml) was added to the vessel (constant stirring; dry nitrogen atmosphere) followed by a specified amount of dipyridamole (7 or 10 mg) in toluene (10 ml). Then Sn(Oct) 2 (10 mg) was added and the temperature was allowed to increase to 100 o C. After heating for 24 h, the cooled reaction mixture was condensed to about half of its original volume (rotary evaporation) and the product was isolated by suction filtration following precipitation from ethanol/hexane (400 ml; 20/80 v/v). The solid product was washed with methanol and dried under reduced pressure.
Hydrolytic weight loss
Hydrolytic weight loss experiments were conducted in vials (2 ml) containing the powdered sample (50 mg) and phosphate buffer solution (PBS; 1 ml). To simulate body temperature and long-term ageing, samples were maintained over specified time scales in a hot air oven at 37 o C and 70 o C. Weight loss was determined gravimetrically (±0.1 mg), following isolation (centrifugation, 5000 rpm) and drying (vacuum oven; 24 h, 70 o C) of the insoluble polymer fraction.
Experiments were performed in triplicate and analysed using the Student's t-test. Weight loss was expressed as a percentage of the original weight.
Separation of the hydrolysis product of star-shaped PLA Star-shaped PLA was hydrolysed by placing accurately weighed samples of the material (ca. 50 mg) in phosphate buffered saline (PBS, 1 ml) at 70 o C for 10 days. The supernatant was separated by centrifugation and the extent of hydrolysis was determined as the weight loss from the dried solid mass that remained in the centrifugation vessel. The diluted supernatant at specified concentrations was used for in vitro and in vivo studies.
MTT toxicity assay
The in vitro cell toxicity of the hydrolyzed products (PBS solution) of star-shaped polymers was ). Controls were provided by cell cultures that had been prepared in the absence of the hydrolysed polymer.
Toxicity was assessed at 24 h intervals. Cells were treated with MTT in PBS (0.5 mg ml 
In vitro assessment of blood compatibility
For the in vitro evaluation of blood compatibility of SSPLA, the hydrolysis product of PLA polymers (5 ml) was mixed with fresh blood (100 µl) and EDTA (5 mmol l -1 ). An aliquot (20 µl) of this mixture was added to hemoglobin solution (5 µl) before incubation (15 min, room temperature) and subsequent evaluation by means of the cyanmethemoglobin method (HEMOCOR-D; 540 nm). The changes in the platelet counts were monitored using a Neubauer's chamber.
Platelet preparation and aggregation assay
Blood platelets drawn from healthy volunteers were placed into an anticoagulant solution (0.15% v/v) of acid-citrate-dextrose (ACD: 38 mM citric acid, 75 mM Na citrate, 124 mM dextrose). 20 Platelet-rich plasma was isolated by centrifugation (180g; 10 min; room temperature) and then acidified to pH 6.5 with ACD and prostaglandin E1 (1 mM). The platelets were pelleted down by centrifugation (750g, 10 min, room temperature), suspended in a mixture of NaCl (130 mM), trisodium citrate (10 mM), NaHCO 3 (9 mM), dextrose (96 mM), MgCl 2 (0.9 mM), KH 2 PO 4 (0.81 mM) and Tris pH 7.4 (10 mM), and then treated with CaCl 2 (1.8 mM). Platelet aggregation studies were performed at 3, 6, 9 and 12 min using a microplate (37 o C; vigorous shaking; optical density measured at 405 nm). At each test concentration, samples of the hydrolysis product of SSPLLA or SSPDLLA in PBS (8 µl) were mixed with aliquots (90 µl) of platelets. Thrombin (0.2 units per ml) and heparin (4 units per ml) were used as positive and negative controls.
Cell adhesion assay
The cell adhesion assay was performed by maintaining (24 h or 48 h) the 3T3-L1-fibroblast cells in culture plates (MEM containing 10% FBS) that had been casted with specified PLA derivatives. A culture well coated with collagen served as a control. After 24 h or 48 h of incubation the culture medium was removed, and followed by washing with PBS, cells were fixed by first adding ethanol Isolation and culture of endothelial cells from rat aorta Rat aorta endothelial cells (RAECs) were isolated from thoracic aortas that had been excised from 3 week-old Sprague-Dawley rats following sacrifice of the animal. Following the removal of the surrounding fibro-adipose tissue (fine dissecting forceps) and after discarding the proximal and distal regions, aortas were cut into 1 mm ring sections and cultured (DMEM containing 10% FCS) in a CO 2 incubator (95% air, 5% CO 2 ; 37 o C), according to the procedure of Nicosia et al. 21 RAECs were sourced from endothelial sprouts that formed from aortic rings and cultured in DMEM containing 10% FCS. The efficacy of the hydrolysis product of SSPLLA or SSPDLLA to promote angio-genesis was assessed by treating these cells with specified concentrations of each degraded polymer. The angiogenic efficacy was evaluated by comparing (LeicaQWIN software
Aortic ring assay for angiogenesis
The aortic ring assay 22 was carried out by exposing aortic rings maintained in DMEM containing 10% FCS to the hydrolytic products of star-shaped PLA. To this end, aortic rings were loaded onto a 24 well plate (10 pieces per well) and cultured (CO 2 incubator) in DMEM containing 10% FCS and specified concentrations of the hydrolysis product of SSPLLA or SSPDLLA.
The efficacy of angiogenesis was evaluated photomicro-graphically, by comparing the sprouting in aortic rings with those in controls (prepared following an identical procedure, but in the absence hydrolytic products of star-shaped PLA) at specified time intervals. The medium was replaced after 24 h. The extent of angiogenic response was quantified (area per µm All animal experiments were performed as per the animal handling protocol conformed to the international standards, and was monitored by the Institutional Ethics Committee.
Chorioallantoic membrane assay
The chorioallantoic membrane (CAM) assay 23 was performed using white Leghorn eggs collected from the poultry research station in Madhavaram, Chennai. Fertilized eggs were incubated in a humidified incubator (37 o C; relative humidity 80%) for four days, after which time the eggs were candled to identify prominent blood vessels and to assess the development of the embryo. A window (1 cm 2 ) was cut over the CAM (small craft-grinding wheel) and test samples were loaded onto a hydro-cortisone-dried filter disk and placed on the CAM at a vascular area near a previously identified prominent blood vessel. The window was sealed with sterile parafilm and the eggs placed back in the incubator. Changes in microvasculature density were assessed (digital imaging) after four days of incubation.
Results and discussions 1 H-and 13 
C-NMR spectroscopy
Star-shaped PLA polymers were synthesized by a coordination intersection reaction in which the Sn(Oct) 2 -catalysed polymerization of L -lactide was initiated by the primary tetra-hydroxyl groups of dipyridamole to give a secondary hydroxyl group-terminated, four-armed structure. The D microstructural order, which in turn influenced the crystalline order and optical activity as shown in Table 1 . Thermal and contact angle behaviour of star-shaped PLA The effects of tacticity on the thermal properties of star-shaped PLA polymers were studied by DSC, Table 2 . Isotactic SSPLLA is semi-crystalline, exhibiting both T g and melting endotherms, whereas heterotactic SSPDLLA is amorphous. Accordingly, 26, 27 the midpoint of the T g range of heterotactic SSPDLLA was seen at a lower temperature (33 o C) than that of isotactic SSPLLA (53 o C), Fig. 4 .
The DSC data indicated that tacticity influenced the molecular arrangement. Contact angle measurements revealed that the order of hydrophilicity, as determined by water contact angles on films, was PLLA > SSPLLA > SSPDLLA; respective contact angles were measured at 80 o , 68 o and 67 o (Fig. 5) . The order of hydrophilicity was further reflected by the rate of hydrolysis, as presented in Fig. 6 . Although average molecular weight may be of some significance, it is assumed that the main factor influencing the rate of hydrolysis is the degree of crystallinity, which in turn is influenced by the tacticity of each polymer. Entry no. Hydrolysis of star-shaped PLA Hydrolysis weight loss of star shaped polylactic acids with different time periods is shown in Fig. 6 .
Weight loss of SSPLLA shows a moderate degradation rate with respect to the crystal-line composition and the crystalline packing of the polymer in general (PLLA (isotactic) crystallized in the a-form with 103 helical conformations). [30] [31] [32] In the stereocomplex of D and L units, SSPDLLA (heterotactic) crystallized based on hydrogen bonding between the methyl and carbonyl group (CH 3  O=C). Zange et al. 33 reported that the CH 3  O=C hydrogen bonding leads to the crystallization with 31 helical conformations in the stereocomplex systems. At the same time, this hydrogen bonding will produce a more amount of amorphous phase in the polymer chain due to the physical cross linking effect. [34] [35] [36] [37] So the amorphous phase of SSPDLLA is higher compared to that of SSPLLA. The DSC results in Fig. 3 clearly indicate that the T g of the SSPDLLA shifted towards lower temperature confirming that the flexibility is more than that of SSPLLA. Here, the higher amorphous phase undergoes random chain scission and the weight loss of the SSPDLLA is more than two folds faster than that of ).
Consistent with the hydrolysis of the polymer to its lactic acid precursors, even at 8 mg ml -1 , there was no evidence of any toxic effect over 72 h. These results indicate the higher proliferative effect of the degradation product of SSPLLA as compared with that of SSPDLLA. On the basis of literature reports, 38, 39 we have concluded that this may be due to the absorption and utilization of the L -form of lactate, which is naturally available in humans as opposed to the D and L mixture found in the degradation products of SSPDLLA. The results indicated that the degradation products of the PLA construct are biocompatible and induce cell proliferation. We have observed that cell adhesion is better in D,L -lactide oligomers, and that L -lactide oligomers exhibited superior blood compatibility. This may be due to the presence of the L -form, biological, lactate. To further assess the anti-platelet aggregating effects of PLA polymers, the effect of the hydrolysis products of SSPLLA and SSPDLLA on platelet aggregation was between the degree of crystallinity and the amount of adhered polymer, it was assumed that the rotational freedom of studied, Fig. 10 : the expected, platelet anti-aggregating proper-ties were observed. Also, the hydrolysis products of both SSPLLA and SSPDLLA demonstrated a concentration-dependent inhibition of platelet aggregation that was similar to that induced by heparin. These results confirmed the anti-platelet aggregating properties of the constructs, indicating that the construct would prevent the inflammatory response that usually is associated with stent implantation. The prevention of initial neo-intima formation thereby reduces the probability of in-stent restenosis. It is assumed that the anti-platelet aggregation properties of PLA polymers are mainly due to the bio-and hemo-compatibility of lactide rather than that of dipyridamole, which is present at low concentrations. However molecular design considerations necessitated the incorporation of the dipyridamole core as a means of preventing initial platelet activation. Blood compatibility and platelet count studies demonstrated that PLA polymers do not elicit any platelet-aggregating effects. Fig. 10 Effect of the hydrolytic products of star-shaped polylactic acids on platelet aggregation. Effect of SSPLLA and SSPDLLA on angiogenesis CAM assay. The CAM assay demonstrated that treatment with SSPLLA or SSPDLLA causes a significant increase in the mean diameter and in the density of microcapillaries (Fig. 11) as compared with both the positive (endothelial growth factor) and negative (endostatin) controls. The efficacy of SSPDLLA to induce angiogenesis in CAM was greater than that of SSPLLA. This is attributed to the amorphous nature of SSPDLLA, compared with SSPLLA, allowing more rapid degradation and releasing increased levels of hydrolysed lactates. This in turn results in increased branching in SSPDLLA-(210 branch points) as compared with SSPLLA-(175 branch points). The degradation rate of SSPDLLA is faster than that of SSPLLA, with the implication that the higher availability of the products of the hydrolysis promotes angiogenesis in the CAM assay. This is further supported by the observation that respective branch points in positive and negative controls were 170 and 45; vascular endothelial growth factor-treated CAM provided the positive control and endostatin-treated CAM was used as the negative control. The increased angiogenic efficacy of the polymer as compared with VEGF may be due to lactide which promotes VEGF production and simultaneously inhibits post-translational modification; namely, the polyADP ribosylation of VEGF increasing biological activity. 10 Since the more rapidly hydrolysable SSPDLLA exhibited the highest angiogenic efficacy, it is assumed that angiogenicity is directly linked to the formation of lactic acid during the degradation process. The effect of the hydrolysis product of PLLA and PDLLA on angio-genesis is presented as ESI. † The results indicated that the rate of the proangiogenic effect is in the order: L -lactate < D,L -lactate < PDLLA < PLLA. Since PDLLA is more readily amenable to biochemical hydrolysis than PLLA, the former material is more proangiogenic. Also, the naturally available L lactate is more proangiogenic than D lactate.
Aortic ring assay. The effect of SSPLLA and SSPDLLA on cell types that are known to be involved in angiogenesis (endothelial cell, fibroblast cells and smooth muscle cells) was assessed by means of an established in vitro tissue explant assay, namely the aortic ring angiogenesis assay. The proangiogenic effects of SSPDLLA and SSPLLA on aortic rings, as indicated by the length and number of aortic sprouts from explants relative to those for the control, are shown in Fig. 12 . Consistent with the CAM assay, the density of aortic ring sprouts that had formed consequent to treatment with SSPDLLA was higher than that induced by SSPLLA. The difference in the rate of angiogenesis in SSPDLLA and SSPLLA may be attributed to the physical nature that dictates the rate of degradation and availability of lactate in the microenvironment to promote angiogenesis.
Effect of SSPLLA and SDPLLA on RAEC differentiation. Consideration of the rate of differentiation of RAECs from a cobblestone morphology to a capillary network-like structure demonstrated a concentration-dependent proangiogenic effect for SSPLLA and SSPDLLA as shown in Fig. 13 . In accordance with expectations, the angiogenic efficacy of SSPDLLA was greater than that of SSPLLA. 
Conclusions
Two star-shaped polylactic acids of differing hydrophilicities have been synthesized and characterised by spectroscopic and analytical techniques. The tacticity of these polymers was found to determine the degree of crystallinity, which in turn was seen to determine hydrolytic stability. A series of in vitro and in vivo experiments have demonstrated that both polymers combine biocompatibility with properties of anti-coagulation and angiogenesis. These properties render the materials suitable candidates for use in coronary stents for the treatment of cardiovascular disease.
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